Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.
Jin N, Keam B, Cho J, Lee MJ, Kim HR, Torosyan H, Jura N, Ng PK, Mills GB, Li H, Zeng Y, Barbash Z, Tarcic G, Kang H, Bauman JE, Kim MO, VanLandingham NK, Swaney DL, Krogan NJ, Johnson DE, Grandis JR.
Jin N, et al. Among authors: torosyan h.
J Clin Invest. 2021 Nov 15;131(22):e150335. doi: 10.1172/JCI150335.
J Clin Invest. 2021.
PMID: 34779417
Free PMC article.